posted on 2021-08-16, 17:38authored byAziz Aiderus, Justin Y. Newberg, Liliana Guzman-Rojas, Ana M. Contreras-Sandoval, Amanda L. Meshey, Devin J. Jones, Felipe Amaya-Manzanares, Roberto Rangel, Jerrold M. Ward, Song-Choon Lee, Kenneth Hon-Kim Ban, Keith Rogers, Susan M. Rogers, Luxmanan Selvanesan, Leslie A. McNoe, Neal G. Copeland, Nancy A. Jenkins, Kenneth Y. Tsai, Michael A. Black, Karen M. Mann, Michael B. Mann
Xenografts of cuSCC human cell lines A431, COLO16 and SCC13 with stable lentiviral constructs expressing shRNAs directed knockdown of target drivers KMT2C (shKMT2C) or NCOA2 (shNCOA2) relative to a non-targeting control (shNTC) grown in NSG immunodeficient mice.